Bellicum announced that data of its HER2-targeted CAR-T cell will be reviewed in a presentation at the 21st Annual Meeting of the American Society of Gene and Cell Therapy.
Bellicum announced that data of its HER2-targeted CAR-T cell will be reviewed in a presentation at the 21st Annual Meeting of the American Society of Gene and Cell Therapy.